XML 65 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 28, 2016
May 26, 2016
Mar. 16, 2016
Oct. 07, 2013
Mar. 24, 2010
Jan. 31, 2016
May 31, 2015
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
May 31, 2016
Dec. 31, 2015
May 31, 2014
Related-Party Transactions (Textual) [Abstract]                            
Long-term other assets               $ 1,482,066   $ 1,482,066     $ 676,803  
Subsidiary ownership percentage by parent                           85.00%
Receivable from sale of intangible assets                       $ 2,000,000    
Future payments to be received from sale of intangible assets             $ 1,000,000              
Ownership of investment             16.90%              
Carrying value of investment                           $ 0
Investment in affiliated entity - PLS               $ 4,537,761   $ 4,537,761     5,045,915  
Available-for-sale Securities [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Investment owned (shares)               395,758   395,758   395,758    
Available-for-sale Securities [Member] | VGX International [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Investment owned (shares)             465,364              
GeneOne Life Sciences [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Milestone-based ownership target   35.00%       35.00%                
Term       20 years                    
Payment received for license granted         $ 3,000,000                  
Deferred revenue from affiliated entity         $ 3,000,000                  
Period over which deferred revenue from affiliated entity will be recognized in years         8 years                  
Revenue from related parties               $ 452,000 $ 113,000 $ 1,000,000 $ 338,000      
Operating expenses related to affiliated entity               801,000 $ 1,100,000 2,100,000 $ 6,500,000      
Accounts receivable balance               355,000   355,000     4,000  
Accounts payable and accrued liability               93,000   93,000     165,000  
Long-term other assets               $ 619,000   $ 619,000     $ 373,000  
OncoSec [Member] | First warrant [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Common stock purchase warrant (in shares) 50,000                          
Exercise price of a five-year warrant ($ per share) $ 24.00                          
OncoSec [Member] | Second warrant [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Common stock purchase warrant (in shares)               150,000   150,000        
Exercise price of a five-year warrant ($ per share)                   $ 20.00        
Director [Member]                            
Related-Party Transactions (Textual) [Abstract]                            
Term     5 years                      
Revenue from related parties               $ 228,000   $ 228,000        
Operating expenses related to affiliated entity               329,000   586,000        
Expenses to reimburse     $ 3,100,000                      
Accounts receivable               39,000   39,000        
Accounts payable/accrued liabilities               $ 401,000   $ 401,000